News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Algorae Pharmaceuticals.
RELATED STOCKHEAD STORIES
Health & Biotech
ASX Health Stocks: Here’s an update on Algorae’s AI-powered drugs discovery platform
Health & Biotech
ASX Health Stocks: US bound Telix plans dual listing on the NASDAQ
Health & Biotech
ASX Health Stocks: Chimeric jumps 35pc as cell therapy drug shows pre-clinical efficacy
News
In Case You Missed It: Lithium land secured in Canada’s Electric Avenue takes PAT higher
Health & Biotech
ASX Health Stocks: Chimeric surges 70pc after FDA approval, takes its CAR T cell drug to the clinic
News
ASX Small Caps and IPO Weekly Wrap: Things went better than expected in a week all about lithium and uranium
News
Rise and Shine: Everything you need to know before the ASX opens
News
Closing Bell: Catch up footy leaves benchmark nibbling at parity for second straight session
News
ASX Small Caps Lunch Wrap: Who’s elevated being drunk and lazy to an art form this week?
News
In Case You Missed It: Construction materials player beats resources for top spot
Health & Biotech
Algorae, UNSW work on ‘revolutionary’ AI platform to accelerate drug discovery and development
News
Market Highlights: Wall Street’s late selloff, home prices rebound, and 5 ASX small caps to watch today
News
ASX Health Stocks: Living Cells Tech files a patent for cannabis-based dementia drug
Health & Biotech
ASX Health Stocks: AVITA’s spray-on skin cells device RECELL pockets US FDA approval
News
CLOSING BELL: Shipments increase after China lifts the ban it never put on Aussie coal
Health & Biotech
As dementia takes toll on Aussies, here’s why Alterity and these ASX biotechs are in the box seat
Health & Biotech
